Qualitative methods in health care research V Renjith, R Yesodharan, JA Noronha, E Ladd, A George International journal of preventive medicine 12 (1), 20, 2021 | 422 | 2021 |
Prescribers and pharmaceutical representatives: why are we still meeting? MA Fischer, ME Keough, JL Baril, L Saccoccio, KM Mazor, E Ladd, ... Journal of general internal medicine 24, 795-801, 2009 | 118 | 2009 |
The use of antibiotics for viral upper respiratory tract infections: an analysis of nurse practitioner and physician prescribing practices in ambulatory care, 1997–2001 E Ladd Journal of the american association of nurse practitioners 17 (10), 416-424, 2005 | 114 | 2005 |
Advanced practice nursing roles, regulation, education, and practice: A global study KJ Wheeler, M Miller, J Pulcini, D Gray, E Ladd, MK Rayens Annals of global health 88 (1), 2022 | 60 | 2022 |
Healthcare inequity and physician scarcity A Sharma, E Ladd, MK Unnikrishnan Economic and Political Weekly 48 (13), 112-117, 2013 | 41 | 2013 |
Nurse prescribing from the global vantage point: the intersection between role and policy E Ladd, M Schober Policy, Politics, & Nursing Practice 19 (1-2), 40-49, 2018 | 28 | 2018 |
" Under the radar": nurse practitioner prescribers and pharmaceutical industry promotions. EC Ladd, DF Mahoney, S Emani The American journal of managed care 16 (12), e358-62, 2010 | 28 | 2010 |
Opioid prescribing by nurse practitioners in Medicare Part D: Impact of state scope of practice legislation E Ladd, CF Sweeney, A Guarino, A Hoyt Medical Care Research and Review 76 (3), 337-353, 2019 | 23 | 2019 |
More than a prescriber: Gerontological nurse practitioners' perspectives on prescribing and pharmaceutical marketing DF Mahoney, E Ladd Geriatric Nursing 31 (1), 17-27, 2010 | 18 | 2010 |
A global SWOT analysis of advanced practice nursing: Policy, regulation, and practice E Ladd, MI Miller, K Wheeler, S Wainaina, F Aguirre, H McGrath, S Lee, ... | 16 | 2020 |
Pharmaceutical industry sponsorship and the NP prescriber: Policy and practice implications E Ladd The Journal for Nurse Practitioners 7 (2), 102-108, 2011 | 11 | 2011 |
A global perspective of advanced practice nursing research: A review of systematic reviews protocol K Kilpatrick, I Savard, LA Audet, A Kra-Friedman, R Atallah, M Jabbour, ... Plos one 18 (1), e0280726, 2023 | 9 | 2023 |
How will the COVID-19 pandemic reshape nursing education globally? AJ Nashwan, JN Waghmare, E Ladd Open Journal of Nursing 10 (10), 973, 2020 | 8 | 2020 |
Randomized controlled trial on the effectiveness of a multicomponent intervention on migraine: A study protocol V Renjith, A Pai, K Radhakrishnan, BS Nayak, ES Devi, E Ladd, A George Journal of Advanced Nursing 74 (3), 734-742, 2018 | 5 | 2018 |
Shedding light on nurse practitioner prescribing E Ladd, A Hoyt The Journal for Nurse Practitioners 12 (3), 166-173, 2016 | 5 | 2016 |
“Nurse Ambassadors”: A New “Fulcrum” Of Pharmaceutical Marketing Q Grundy, E Ladd Health Affairs Forefront, 2019 | 4 | 2019 |
Pharmaceutical Industry Interactions With Nonprescribing Clinicians: A Complex Web of Influence E Ladd, A Hoyt JAMA Internal Medicine 176 (11), 1720-1721, 2016 | 4 | 2016 |
Guidelines on prescriptive authority for nurses 2021 D Stewart, M Schober, L Nissen, E Ladd, K Lamarche, ML Bournival, ... | 2 | 2021 |
Substandard housing and the risk of COVID-19 infection and disease severity: A retrospective cohort study K Robb, R Ahmed, J Wong, E Ladd, J de Jong SSM-Population Health 25, 101629, 2024 | 1 | 2024 |
A global perspective of advanced practice nursing research: A review of systematic reviews: protocol C Henderson, A Kra-Friedman, LA Audet, I Savard, LA Spies, H McGrath, ... PROSPERO-University of York, 2021 | 1 | 2021 |